Insulin Makers Blast Patients' 3rd Bid For RICO Claims
Drugmakers Novo Nordisk, Sanofi-Aventis and Eli Lilly and Co. have urged a New Jersey federal judge to nix state racketeering claims filed by diabetics over allegedly excessive insulin prices for the...To view the full article, register now.
Already a subscriber? Click here to view full article